{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:53:00Z","timestamp":1775807580119,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05620-6","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T11:02:25Z","timestamp":1719486145000},"page":"3099-3106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5517-8637","authenticated-orcid":false,"given":"Lukas","family":"Joos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Gonzalez Chiappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-9115","authenticated-orcid":false,"given":"Alfred","family":"Mahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"5620_CR1","unstructured":"Ogino MH, Tadi PC (2023). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553087\/"},{"issue":"2","key":"5620_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1078155220920690","volume":"27","author":"HM Almalag","year":"2021","unstructured":"Almalag HM, Alasmari SS, Alrayes MH, Binhameed MA, Alsudairi RA, Alosaimi MM, Alnasser GA, Abuzaid RA, Khalil N, Abouzaid HH, Alarfaj AS (2021) Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: a cohort study and comprehensive literature review. J Oncol Pharm Pract 27(2):340\u2013349. https:\/\/doi.org\/10.1177\/1078155220920690","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"5620_CR3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/art.30296","volume":"63","author":"G Le Guenno","year":"2011","unstructured":"Le Guenno G, Mahr A, Pagnoux C, Dhote R, Guillevin L, French Vasculitis Study G (2011) Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis Rheum 63(5):1435\u20131445. https:\/\/doi.org\/10.1002\/art.30296","journal-title":"Arthritis Rheum"},{"issue":"7","key":"5620_CR4","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jnci\/87.7.524","volume":"87","author":"LB Travis","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, Holowaty EJ, Van Leeuwen FE, Lynch CF, Hagenbeek A, Stovall M, Banks PM, Adami J et al (1995) Bladder and kidney cancer following cyclophosphamide therapy for non-hodgkin\u2019s lymphoma. J Natl Cancer Inst 87(7):524\u2013530. https:\/\/doi.org\/10.1093\/jnci\/87.7.524","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"5620_CR5","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3899\/jrheum.150065","volume":"42","author":"N Yilmaz","year":"2015","unstructured":"Yilmaz N, Emmungil H, Gucenmez S, Ozen G, Yildiz F, Balkarli A, Kimyon G, Coskun BN, Dogan I, Pamuk ON, Yasar S, Cetin GY, Yazici A, Ergulu Esmen S, Cagatay Y, Yilmaz S, Cefle A, Sayarlioglu M, Kasifoglu T, Karadag O, Pehlivan Y, Dalkilic E, Kisacik B, Cobankara V, Erken E, Direskeneli H, Aksu K, Yavuz S (2015) Incidence of Cyclophosphamide-induced urotoxicity and protective effect of Mesna in Rheumatic diseases. J Rheumatol 42(9):1661\u20131666. https:\/\/doi.org\/10.3899\/jrheum.150065","journal-title":"J Rheumatol"},{"issue":"8","key":"5620_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/rheumatology\/keu372","volume":"54","author":"M Faurschou","year":"2015","unstructured":"Faurschou M, Mellemkjaer L, Voss A, Keller KK, Hansen IT, Baslund B (2015) Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis. Rheumatology (Oxford) 54(8):1345\u20131350. https:\/\/doi.org\/10.1093\/rheumatology\/keu372","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"5620_CR7","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1136\/ard.2003.019125","volume":"63","author":"A Knight","year":"2004","unstructured":"Knight A, Askling J, Granath F, Sparen P, Ekbom A (2004) Urinary bladder cancer in Wegener\u2019s granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 63(10):1307\u20131311. https:\/\/doi.org\/10.1136\/ard.2003.019125","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5620_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7326\/0003-4819-124-5-199603010-00003","volume":"124","author":"C Talar-Williams","year":"1996","unstructured":"Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC (1996) Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 124(5):477\u2013484. https:\/\/doi.org\/10.7326\/0003-4819-124-5-199603010-00003","journal-title":"Ann Intern Med"},{"issue":"1","key":"5620_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/art.25061","volume":"62","author":"PA Monach","year":"2010","unstructured":"Monach PA, Arnold LM, Merkel PA (2010) Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum 62(1):9\u201321. https:\/\/doi.org\/10.1002\/art.25061","journal-title":"Arthritis Rheum"},{"key":"5620_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","volume":"100","author":"EL Matz","year":"2017","unstructured":"Matz EL, Hsieh MH (2017) Review of advances in Uroprotective agents for Cyclophosphamide- and ifosfamide-induced hemorrhagic cystitis. Urology 100:16\u201319. https:\/\/doi.org\/10.1016\/j.urology.2016.07.030","journal-title":"Urology"},{"issue":"1","key":"5620_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1200\/JCO.2008.17.2627","volume":"27","author":"ML Hensley","year":"2009","unstructured":"Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A 3rd, von Hoff D, Schuchter LM (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27(1):127\u2013145. https:\/\/doi.org\/10.1200\/JCO.2008.17.2627","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"5620_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00393-017-0394-1","volume":"76","author":"JH Schirmer","year":"2017","unstructured":"Schirmer JH, Aries PM, de Groot K, Hellmich B, Holle JU, Kneitz C, Kotter I, Lamprecht P, Muller-Ladner U, Reinhold-Keller E, Specker C, Zanker M, Moosig F (2017) [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis]. Z Rheumatol 76(Suppl 3):77\u2013104. https:\/\/doi.org\/10.1007\/s00393-017-0394-1","journal-title":"Z Rheumatol"},{"issue":"Suppl 2","key":"5620_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","volume":"15","author":"B Terrier","year":"2020","unstructured":"Terrier B, Darbon R, Durel CA, Hachulla E, Karras A, Maillard H, Papo T, Puechal X, Pugnet G, Quemeneur T, Samson M, Taille C, Guillevin L, Collaborators (2020) French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Orphanet J Rare Dis 15(Suppl 2):351. https:\/\/doi.org\/10.1186\/s13023-020-01621-3","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"5620_CR14","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D\u2019Cruz D, Harper L, Jayne D, Luqmani R, Mills J, Mooney J, Venning M, Watts RA, Bsr, Bhpr Standards G, Audit Working G (2014) BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford) 53(12):2306\u20132309. https:\/\/doi.org\/10.1093\/rheumatology\/ket445","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"5620_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.24634","volume":"73","author":"SA Chung","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA (2021) 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of Antineutrophil cytoplasmic antibody-Associated Vasculitis. Arthritis Care Res (Hoboken) 73(8):1088\u20131105. https:\/\/doi.org\/10.1002\/acr.24634","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"5620_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75(9):1583\u20131594. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209133","journal-title":"Ann Rheum Dis"},{"key":"5620_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","author":"B Hellmich","year":"2023","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"5620_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7326\/0003-4819-142-4-200502150-00008","volume":"142","author":"NK Choudhry","year":"2005","unstructured":"Choudhry NK, Fletcher RH, Soumerai SB (2005) Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med 142(4):260\u2013273. https:\/\/doi.org\/10.7326\/0003-4819-142-4-200502150-00008","journal-title":"Ann Intern Med"},{"issue":"3","key":"5620_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pbc.20617","volume":"49","author":"SL Khaw","year":"2007","unstructured":"Khaw SL, Downie PA, Waters KD, Ashley DM, Heath JA (2007) Adverse hypersensitivity reactions to mesna as adjunctive therapy for cyclophosphamide. Pediatr Blood Cancer 49(3):341\u2013343. https:\/\/doi.org\/10.1002\/pbc.20617","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"5620_CR20","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2230.2011.04233.x","volume":"37","author":"CY Lin","year":"2012","unstructured":"Lin CY, Keefe M (2012) Mesna-induced photodistributed dermatosis. Clin Exp Dermatol 37(4):358\u2013360. https:\/\/doi.org\/10.1111\/j.1365-2230.2011.04233.x","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"5620_CR21","first-page":"444","volume":"25","author":"A Soria","year":"2015","unstructured":"Soria A, Lebrun-Vignes B, Le Forestier N, Frances C (2015) Fixed drug eruption due to Mesna. J Investig Allergol Clin Immunol 25(6):444\u2013445.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"4","key":"5620_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.anai.2011.06.025","volume":"107","author":"KM Weiss","year":"2011","unstructured":"Weiss KM, Jariwala S, Wachs J, Jerschow E (2011) Fixed drug eruption caused by mesna. Ann Allergy Asthma Immunol 107(4):377\u2013378. https:\/\/doi.org\/10.1016\/j.anai.2011.06.025","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05620-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05620-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T16:04:38Z","timestamp":1733328278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05620-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5620"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05620-6","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and consent was not required for the research reported in the submitted work because it did not collect health-related personal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This work was presented at the EULAR 2021 virtual congress (June 2\u20135, 2021) (Joos L, Gonzalez Chiappe S, Neumann T, Mahr A (2021) AB0388 Use of mesna prophylaysis in cyclophosphamide-treated patients with ANCA-associated vasculitis: results of an electronic survey. Ann Rheum Dis 80(Suppl 1):1222. ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}